2018 Ç¥ÀûÄ¡·á¿¬±¸È¸ Ãß°è½ÉÆ÷Áö¾ö : 2018-10-06±³À°ÀÏÀÚ : 2018-10-06
±³À°Àå¼Ò : ¼¿ï¼º¸ðº´¿øÁöÇÏ1Ãþ ´ë°´ç
±³À°ÁÖÁ¦ :
2018 Ç¥ÀûÄ¡·á¿¬±¸È¸ Ãß°è½ÉÆ÷Áö¾ö ÁÖÃÖ±â°ü : ´ëÇÑÆó¾ÏÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : Ç¥ÀûÄ¡·á¿¬±¸È¸
´ã´çÀÚ : ½É¹Î°æ
¿¬¶ôó : 02-741-8540
À̸ÞÀÏ :
kalc@lungca.or.kr ±³À°Á¾·ù : ³»°ú, ÈäºÎ¿Ü°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, º´¸®°ú, °¡Á¤ÀÇÇаú, ÇÙÀÇÇаú
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 3 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 80,000¿ø
ºñ°í »çÀüµî·Ï: ȸ¿ø/50,000,ºñȸ¿ø/70,000 ÇöÀåµî·Ï ȸ¿ø/60,000, ºñȸ¿ø/80,000
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10¿ù 06ÀÏ ´ë°´ç 13:00~13:30 Murine models – fit or unfit? °ÅÂÈï(°Ç±¹ÀÇ´ë)
±³À°½Ã°£ 10¿ù 06ÀÏ ´ë°´ç 13:30~14:00 Oragnoids – better than mouse? À¯Á¾¸¸(Â÷ÀÇ°ú´ë)
ÈÞ½Ä 10¿ù 06ÀÏ ´ë°´ç 14:00~14:20 ÈÞ½Ä ()
±³À°½Ã°£ 10¿ù 06ÀÏ ´ë°´ç 14:20~14:40 EGFR targeted therapy – awaiting the next move ÀÌâ·ü(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 10¿ù 06ÀÏ ´ë°´ç 14:40~15:00 ALK targeted therapy – the best subgroup in advanced stage? ÃÖ¼öÀÎ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 10¿ù 06ÀÏ ´ë°´ç 15:00~15:20 Therapy for low-frequency target – hope for orphans ±¸¼Ò¹Ì(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 10¿ù 06ÀÏ ´ë°´ç 15:20~15:40 Recent advances in NGS for targeted therapy ³ë¹Ì¼÷(µ¿¾ÆÀÇ´ë)
ÈÞ½Ä 10¿ù 06ÀÏ ´ë°´ç 15:40~16:00 ÈÞ½Ä ()
±³À°½Ã°£ 10¿ù 06ÀÏ ´ë°´ç 16:00~16:30 Clinical trial – stepping into real-world practice ¹Úµ¿¿ø(ÇѾçÀÇ´ë)
±³À°½Ã°£ 10¿ù 06ÀÏ ´ë°´ç 16:30~17:00 Pre-clinical research – inspiring aspects for young investigators ÇãÀº¿µ(¼¿ïÀÇ´ë)